KCTD7 antibody (AA 181-230)
Quick Overview for KCTD7 antibody (AA 181-230) (ABIN8123885)
Target
See all KCTD7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 181-230
-
Purpose
- KCTD7 Antibody
-
Specificity
- This antibody detects endogenous levels of KCTD7
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from human KCTD7. at AA range: 181-230
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:500-2000,IHC 1:50-300, ELISA 2000-20000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C/1 year
-
Expiry Date
- 12 months
-
-
- KCTD7 (Potassium Channel Tetramerisation Domain Containing 7 (KCTD7))
-
Alternative Name
- KCTD7
-
Background
-
Synonyms: BTB/POZ domain-containing protein KCTD7
Background: This gene encodes a member of the potassium channel tetramerization domain-containing protein family. Family members are identified on a structural basis and contain an amino-terminal domain similar to the T1 domain present in the voltage-gated potassium channel. Mutations in this gene have been associated with progressive myoclonic epilepsy-3. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2011],
Gene Name: KCTD7
Protein Name: KCTD7
-
Gene ID
- 154881
-
UniProt
- Q96MP8
Target
-